Oncology Nurse Advisor » Lymphoma
0 FOLLOWERS
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Oncology Nurse Advisor » Lymphoma
1w ago
Women have increased risk for thyroid, renal, lung cancers; men have highest risk for melanoma, bladder, prostate cancers ..read more
Oncology Nurse Advisor » Lymphoma
3w ago
Researchers sought to determine whether adding romidepsin to CHOP would be effective compared with CHOP alone as first-line treatment of PTCL ..read more
Oncology Nurse Advisor » Lymphoma
1M ago
Researchers sought to determine healthcare resource utilization associated with lisocabtagene maraleucel compared with axicabtagene ciloleucel in patients with LBCL ..read more
Oncology Nurse Advisor » Lymphoma
2M ago
Stratification based on prelymphodepletion C-reactive protein, ferritin can classify patients into high, intermediate, and low risk ..read more
Oncology Nurse Advisor » Lymphoma
2M ago
Changes to modern treatment protocols for pediatric Hodgkin lymphoma seem to have reduced late cardiotoxicity ..read more
Oncology Nurse Advisor » Lymphoma
2M ago
Researchers sought to better characterize the disease features, patient characteristics, and the effects of immunodeficiency on survival among patients with plasmablastic lymphoma ..read more
Oncology Nurse Advisor » Lymphoma
2M ago
Researchers sought to determine whether MRD status would be predictive of outcomes after induction and during maintenance in previously untreated patients with FL ..read more
Oncology Nurse Advisor » Lymphoma
3M ago
Researchers sought to determine whether golidocitinib would have antitumor activity among patients with relapsed/refractory PTCL ..read more
Oncology Nurse Advisor » Lymphoma
3M ago
Meta-analysis identifies risk factors for venous thromboembolism in patients with lymphoma ..read more
Oncology Nurse Advisor » Lymphoma
3M ago
CD5-directed CAR-T cells can produce responses in patients with relapsed or refractory T-cell lymphoma, data suggest ..read more